Peter, trevor;
Ellenberger, dennis;
Boeras, debrah;
Kim, andrea A;
Messele, tsehaynesh;
Roberts, teri;
Stevens, wendy;
Jani, ilesh;
Abimiku, alash'le;
Ford , nathan;
Katz, Zachary;
Nkengasong, john N.
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the benefits of suppressed viral load for the individual and the whole population. Historically, large-scale diagnostic tes...
Anti-HIV Agents/therapeutic use,
Antiretroviral Therapy, Highly Active/methods,
Drug Monitoring,
HIV Infections/drug therapy,
Health Policy,
Medical Laboratory Science,
Blood/virology,
Desiccation/methods,
Global Health,
HIV Infections/prevention & control,
HIV Infections/virology,
Medical Laboratory Science/organization & administration,
Specimen Handling/methods,
Viral Load
Jani, ilesh, v;
Meggi, bindiya;
Vubil, adolfo;
Bhatt, nilesh;
Tobaiwa, ocean;
Quevedo, jorge, i;
Loquiha, osvaldo;
Lehe, jonathan, d;
Vojnov, lara;
Peter, trevor, f.
Viral load testing is the WHO-recommended monitoring assay for patients on HIV antiretroviral therapy (ART). Point-of-care (POC) assays may help improve access to viral load testing in resource-limited settings. We compared the performance of the Alere Q NAT POC viral load technology (Alere Technologies,...
Background: An observational study was conducted in Maputo, Mozambique, to investigate trends in prevalence of HIV drug resistance (HIVDR) in antiretroviral (ART) naïve subjects initiating highly active antiretroviral treatment (HAART).
Methodology/principal findings: To evaluate the pattern of drug res...
Ambulatory Care,
Antiretroviral Therapy, Highly Active,
CD4 Lymphocyte Count,
Drug Resistance, Viral,
HIV Infections/epidemiology,
HIV-1/drug effects,
Host-Pathogen Interactions,
Mutation,
Prevalence,
Treatment Failure,
Viral Load/radiation effects,
Anti-Retroviral Agents/therapeutic use,
Drug Resistance, Viral/genetics,
Genotype,
HIV Infections/rehabilitation,
HIV Infections/virology,
HIV-1/genetics,
HIV-1/physiology,
Viral Load/genetics
Viegas, edna omar;
Tembe, nelson;
Macovela, eulália;
Gonçalves, emília;
Augusto, orvalho;
Ismael, nalia;
Sitoe, Nádia;
Schacht, caroline de;
Bhatt, nilesh;
Meggi, bindiya;
Araújo, carolina;
Sandström, eric;
Biberfeld, gunnel;
Nilsson, charlotta;
Andersson, sören;
Jani, Ilesh.
Background: Prevalence of HIV in Mozambique among individuals aged 15-49 years is 11.5%. The HIV prevalence is higher in women than in men across the country, peaking at ages 25-29 years and 35-39 years, respectively. In this study, we aimed at determining the prevalence and incidence of HIV, prevalence ...
Viegas, Edna Omar;
Tembe, Nelson;
Macovela, Eulália;
Gonçalves, Emília;
Augusto, Orvalho;
Ismael, Nália;
Sitoe, Nádia;
Schacht, Caroline De;
Bhatt, Nilesh;
Meggi, Bindiya;
Araujo, Carolina;
Sandström, Eric;
Biberfeld, Gunnel;
Nilsson, Charlotta;
Andersson, Sören;
Jani, Ilesh;
Osman, Nafissa.
Background: Prevalence of HIV in Mozambique among individuals aged 15-49 years is 11.5%. The HIV prevalence is higher in women than in men across the country, peaking at ages 25-29 years and 35-39 years, respectively. In this study, we aimed at determining the prevalence and incidence of HIV, prevalence ...
Em 1986 foi diagnosticado o primeiro caso de infecção pelo HIV em Moçambique.
Actualmente, estima-se que cerca de 1.4 milhões de pessoas vivem com o HIV/
SIDA, sendo que destas, 200.000 são crianças (0-14 anos), 460.000 homens e
770.000 são mulheres1.
De acordo com o Inquérito Nacional de Preval...
Segundo OMS, em 2013 aproximadamente 35 milhões de pessoas no Mundo estavam infectadas pelo HIV e destes, aproximadamente 24,7 milhões viviam na África Subsariana. Em Moçambique, a prevalência é de 11,5% na população com 15-49 anos de idade. O aumento da prevalência do HIV na década de 80, prov...
Immunologic Deficiency Syndromes,
Sexually Transmitted Diseases,
Tuberculosis,
T-Lymphocytes,
HIV Infections,
CD4 Antigens,
Cells,
Viral Load,
Prevalence,
Immune System,
Patients,
Health Centers
O Sarcoma de Kaposi (SK) é um tumor vascular de baixo grau do sangue e dos vasos linfáticos, com evolução clínica muito variável, que frequentemente se apresenta na forma de lesões cutâneas; Histologicamente caracteriza-se por proliferação de vasos sanguíneos, de células fusiformes, inflamaç...
Training Support,
HIV,
CD4 Antigens,
Antigens,
Cells,
Dermatology,
Diagnosis,
Inflammation,
Minors,
Patients,
Viral Load,
Viruses,
Sarcoma, Kaposi,
Clinical Evolution,
Wounds and Injuries
The scale-up of effective HIV viral load (VL) testing is an urgent public health priority. Implementation of testing
is supported by the availability of accurate, nucleic acid based laboratory and point-of-care (POC) VL technologies and strong
WHO guidance recommending routine testing to identify treatme...
Background: The prevalence of hepatitis B virus (HBV) infection and human immunodeficiency virus (HIV) infection in Mozambique is one of the highest in the world, though in spite of this the prevalence of occult hepatitis B infection (OBI) is unknown.
Objectives: This study was conducted with the aim to ...
Anti-HIV Agents/therapeutic use,
DNA, Viral/genetics,
HIV Infections/complications,
Hepatitis B/complications,
Hepatitis B/diagnosis,
Hepatitis B virus/genetics,
Mozambique,
Hepatitis B virus/isolation & purification,
d0065140,
Viral Load
